Your browser doesn't support javascript.
loading
Cost-effectiveness analysis of the Parkinson's KinetiGraph and clinical assessment in the management of Parkinson's disease.
Chaudhuri, K Ray; Hand, Annette; Obam, Fallon; Belsey, Jonathan.
Afiliación
  • Chaudhuri KR; Department of Basic and Clinical Neurosciences, Institute of Psychiatry, Psychology & Neuroscience, King's College London, and. Parkinson's Foundation Centre of Excellence, King's College Hospital, London, United Kingdom.
  • Hand A; Newcastle Upon Tyne Hospitals NHS Foundation Trust, Clinical Ageing Research Unit, Campus for Ageing and Vitality, Newcastle upon Tyne, United Kingdom.
  • Obam F; JB Medical Ltd, Sudbury, Suffolk, United Kingdom.
  • Belsey J; JB Medical Ltd, Sudbury, Suffolk, United Kingdom.
J Med Econ ; 25(1): 774-782, 2022.
Article en En | MEDLINE | ID: mdl-35593687
Hospital doctors caring for people with Parkinson's disease (PwP) regularly monitor and assess their patients' symptoms, relying on patient recall and patient-completed diaries to find out about current symptoms, which can be unreliable. The Parkinson's KinetiGraph (PKG) is a wrist-worn device that collects continuous information on movement in PwP. A report is then provided to the patient's Consultant helping them to understand the PwP's symptoms and make decisions about changing medication to improve symptom control.An economic model compared asking patients to wear a PKG device for 6 days before their check-up appointment with their Consultant with usual check-up without the PKG. Information from a clinical trial exploring the use of PKG provided data on Movement Disorder Society ­ Unified Parkinson's Disease Rating Scale (MDS-UPDRS) II and III scores, which were used in the model to predict improvements in quality of life and whether PwP had controlled or uncontrolled disease.The model showed that addition of PKG to usual check-ups is a cost-effective approach. Use of the PKG reduced costs (£141,950 versus £159,312 for usual check-ups) and had a positive impact on quality and quantity of life as measured by quality adjusted life years (7.88 versus 7.61).This study shows that adding the PKG to routine check-ups allows Consultants to accurately assess movement (or motor) symptoms in PwP, which can then be used to ensure optimal mediation choice and improve patient outcomes.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson Tipo de estudio: Clinical_trials / Health_economic_evaluation / Prognostic_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: J Med Econ Asunto de la revista: SERVICOS DE SAUDE Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson Tipo de estudio: Clinical_trials / Health_economic_evaluation / Prognostic_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: J Med Econ Asunto de la revista: SERVICOS DE SAUDE Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido